Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.

Saved in:
Bibliographic Details
Title: Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
Authors: Smith RM; Medicine, University of Cambridge, Cambridge, UK rms50@cam.ac.uk., Jones RB; Renal Medicine, Addenbrooke's Hospital, Cambridge, UK., Specks U; Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA., Bond S; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Nodale M; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Al-Jayyousi R; Nephrology, University Hospitals of Leicester NHS Trust, Leicester, UK., Andrews J; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, UK., Bruchfeld A; Nephrology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Camilleri B; Nephrology, Ipswich Hospital NHS Trust, Ipswich, UK., Carette S; Rheumatology, University of Toronto, Toronto, Ontario, Canada., Cheung CK; Nephrology, University of Leicester, Leicester, UK., Derebail V; Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Doulton T; Nephrology, East Kent Hospitals University NHS Foundation Trust, Canterbury, UK., Ferraro A; Nephrology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Forbess L; Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Fujimoto S; Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Furuta S; Allergy and Clinical Immunology, Chiba University, Chiba, Japan., Gewurz-Singer O; Rheumatology, University of Michigan, Ann Arbor, Michigan, USA., Harper L; Nephrology, University of Birmingham, Birmingham, UK., Ito-Ihara T; The Clinical and Translational Research Center, Kyoto Prefectural University of Medicine, Kyoto, Japan., Khalidi N; Medicine, McMaster University, Hamilton, Ontario, Canada., Klocke R; Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, UK., Koening C; Rheumatology, The University of Utah, Salt Lake City, Utah, USA., Komagata Y; First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan., Langford C; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Lanyon P; Rheumatology, Nottingham University Hospital, Nottingham, UK., Luqmani R; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science (NDORMs), University of Oxford, Oxford, UK., McAlear C; Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Moreland LW; Medicine/Rheumatology, University of Pittsburg, Pittsburg, Pennsylvania, USA., Mynard K; Vasculitis and lupus clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Nachman P; UNC Kidney Center, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Pagnoux C; Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Peh CA; Nephrology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Pusey C; Medicine, Imperial College London, London, UK., Ranganathan D; Medicine, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Rhee RL; Rheumatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Spiera R; Rheumatology, Hospital for Special Surgery, New York, New York, USA., Sreih AG; Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Tesar V; Medicine, Charles University, Praha, Czech Republic., Walters G; Nephrology, Australian National University Medical School, Canberra, Australian Capital Territory, Australia., Wroe C; Nephrology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK., Jayne D; Medicine, Addenbrooke's Hospital, Cambridge, UK., Merkel PA; Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Corporate Authors: RITAZAREM co-investigators
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Jul; Vol. 82 (7), pp. 937-944. Date of Electronic Publication: 2023 Mar 23.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1136/ard-2022-223559